Top 5 Stocks to Buy Now >
→ A huge SpaceX error just led one stock to 3X move! (From InvestPub) (Ad)tc pixel

Biotech Articles

A businessman in a suit stands on a high-rise ledge as colorful pharmaceutical capsules spill over the edge.
June 11, 2026 10:25 AM ET

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

Jeffrey Neal Johnson
NASDAQ:NUVLNYSE:GSKNYSE:PFE
Read Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
A laboratory desk displays a tablet with health icons, a microscope, DNA model, and hourglass, with researchers working in the background.
June 8, 2026 5:40 AM ET

3 Longevity ETFs to Buy and Hold (and Hold)

Nathan Reiff
NYSEARCA:XBINYSEARCA:BMEDNASDAQ:AGNG
Read 3 Longevity ETFs to Buy and Hold (and Hold)
Glass cube labeled ETF on trading desk with stock charts, symbolizing equal-weight ETF strategy
June 7, 2026 6:45 AM ET

3 ETFs For the Coming Genomics Revolution

Nathan Reiff
BATS:ARKGBATS:HELXNYSEARCA:IDNA
Read 3 ETFs For the Coming Genomics Revolution
A rocket lifts off from a coastal launch pad at sunset.
June 4, 2026 8:50 AM ET

Before the IPO: 4 Companies That Rewarded Investors Who Got In Early

Bridget Bennett
NYSEAMERICAN:FJETNYSE:BUDNASDAQ:CNXU
Read Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
Co-Dx logo overlaid on a laboratory scene featuring a multi-channel pipette and sample plates.
May 28, 2026 9:00 AM ET

Is Co-Diagnostics National Security’s Next Diagnostic Pick?

Jeffrey Neal Johnson
NASDAQ:OSURNASDAQ:CODXNASDAQ:GOVX
Read Is Co-Diagnostics National Security’s Next Diagnostic Pick?
Amylyx Pharmaceuticals logo displayed over a blurred laboratory setting with vials and a microscope.
May 24, 2026 6:50 AM ET

Amylyx Stock: Why the Full Pipeline Story Matters

Chris Markoch
NASDAQ:AMLXNASDAQ:REGNNYSE:MRK
Read Amylyx Stock: Why the Full Pipeline Story Matters
Kiniksa Pharmaceuticals logo displayed on laboratory equipment surrounded by vials and petri dishes.
May 23, 2026 5:50 AM ET

Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally

Chris Markoch
NASDAQ:KNSA
Read Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
A gloved scientist handles a syringe vial in a biotech lab with DNA overlay.
May 22, 2026 5:50 AM ET

Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish

Chris Markoch
NASDAQ:BIIBNASDAQ:APLS
Read Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
GLP-1 weight-loss medication bottle and capsules on a desk with glasses and notebook, illustrating the expanding obesity drug market.
May 20, 2026 12:55 PM ET

From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook

Leo Miller
NYSE:LLYNYSE:NVO
Read From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook
Mirum Pharmaceuticals logo displayed over a blurred laboratory setting with scientific equipment.
May 20, 2026 10:35 AM ET

Mirum Pharma: A Rare Disease Growth Story to Watch

Chris Markoch
NASDAQ:MIRM
Read Mirum Pharma: A Rare Disease Growth Story to Watch
Assorted pharmaceutical pills, a medicine vial, and a syringe arranged on a laboratory bench.
May 15, 2026 5:05 AM ET

2 Ways to Play the Big Pharma Patent Cliff

Nathan Reiff
NYSEARCA:XBINASDAQ:IBBNYSE:PFE
Read 2 Ways to Play the Big Pharma Patent Cliff
Lilly-branded insulin pen and vial on a desk beside a digital scale and measuring tape, representing diabetes treatment.
May 7, 2026 8:05 AM ET

What the FDA's Latest Proposal Means for Lilly, Novo, and Hims

Leo Miller
NYSE:LLYNYSE:NVONYSE:HIMS
Read What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
Illustration showing a glowing green upward arrow alongside DNA strands, a pill capsule, and molecular structures outside a modern office building.
May 2, 2026 6:45 AM ET

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat

Jessica Mitacek
NYSE:ABBVNYSE:AZNNYSE:GSK
Read The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat
Eli Lilly logo overlaid on a person in a white coat holding assorted pills and capsules.
May 1, 2026 11:05 AM ET

Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent

Nathan Reiff
NYSE:LLYNYSE:NVO
Read Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
Viking Therapeutics logo displayed alongside a decorative DNA double helix model on a marble surface.
May 1, 2026 8:45 AM ET

Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge

Chris Markoch
NASDAQ:VKTXNYSE:LLYNYSE:NVO
Read Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
AbbVie logo displayed above a medical vial and syringe on a laboratory surface.
April 29, 2026 12:50 PM ET

AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?

Thomas Hughes
NYSE:ABBVNYSE:ABT
Read AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?
A robotic arm dispenses liquid into a multi-well plate in an automated pharmaceutical laboratory setting.
April 27, 2026 5:05 AM ET

3 Biotech Stocks That Could Benefit from the Patent Cliff

Chris Markoch
NASDAQ:NTLANASDAQ:BEAMNASDAQ:CRSP
Read 3 Biotech Stocks That Could Benefit from the Patent Cliff
Johnson & Johnson logo in front of a clean countertop background.
April 14, 2026 12:10 PM ET

Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results

Thomas Hughes
NYSE:JNJ
Read Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results
Close-up of U.S. dollar bills with “dividends” label and growing coin stacks.
April 9, 2026 12:00 PM ET

3 Dividend Aristocrats Whose Yields Can Help Combat Inflation

Chris Markoch
NYSE:AMCRNYSE:CVXNYSE:ABBV
Read 3 Dividend Aristocrats Whose Yields Can Help Combat Inflation
Photorealistic Eli Lilly lab display with branded glass sign and assorted prescription pill bottles on a clean counter.
April 2, 2026 10:15 AM ET

Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience

Jeffrey Neal Johnson
NYSE:LLY
Read Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience
Merck logo displayed on a petri dish, symbolizing pharmaceutical innovation and oncology-focused acquisitions.
March 31, 2026 5:58 AM ET

Merck Just Made a Big Bet on a New Cancer Growth Engine

Jessica Mitacek
NYSE:MRKNYSE:LLYNYSE:ABBV
Read Merck Just Made a Big Bet on a New Cancer Growth Engine

More Articles by Topic

Article Topics

All Articles

Instant Alert Topics

All Instant Alerts